These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1817962)

  • 1. Inhibition of leukotriene biosynthesis in the rat peritoneal cavity.
    Young PR; Bell RL; Lanni C; Summers JB; Brooks DW; Carter GW
    Eur J Pharmacol; 1991 Dec; 205(3):259-66. PubMed ID: 1817962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-lipoxygenase inhibitory activity of zileuton.
    Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
    J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.
    Malo PE; Bell RL; Shaughnessy TK; Summers JB; Brooks DW; Carter GW
    Pulm Pharmacol; 1994 Apr; 7(2):73-9. PubMed ID: 8081074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-leukotriene effects of WY-50,295 tromethamine in isolated guinea pig pulmonary tissues.
    Heaslip RJ; Grimes D; Berkenkopf JW; Ilsemann BA; Sickels BD; Weichman BM
    Eur J Pharmacol; 1993 Apr; 234(2-3):247-54. PubMed ID: 8482329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat.
    Rao TS; Currie JL; Shaffer AF; Isakson PC
    Life Sci; 1993; 53(9):PL147-52. PubMed ID: 8394967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity.
    Griffiths RJ; Li SW; Wood BE; Blackham A
    Agents Actions; 1991 Mar; 32(3-4):312-20. PubMed ID: 1650524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.
    Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A
    Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-78773: a selective, potent 5-lipoxygenase inhibitor.
    Bell RL; Brooks DW; Young PR; Lanni C; Stewart AO; Bouska J; Malo PE; Carter GW
    J Lipid Mediat; 1993; 6(1-3):259-64. PubMed ID: 8395248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.
    Bell RL; Bouska J; Young PR; Lanni C; Machinist J; Malo PE; Summers JB; Brooks DW; Carter GW
    Agents Actions; 1993 Mar; 38(3-4):178-87. PubMed ID: 8213344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat.
    Foster A; Letts G; Charleson S; Fitzsimmons B; Blacklock B; Rokach J
    J Immunol; 1988 Nov; 141(10):3544-50. PubMed ID: 2846689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
    Bailie MB; Dahm LJ; Peters-Golden M; Harris RR; Carter GW; Roth RA
    Toxicology; 1995 Jun; 100(1-3):139-49. PubMed ID: 7624871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells.
    Yamashita M; Kushihara M; Hirasawa N; Takasaki W; Takahagi H; Takayanagi M; Ohuchi K
    Br J Pharmacol; 2000 Jan; 129(2):367-73. PubMed ID: 10694244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
    Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
    Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton.
    Coffey MJ; Phare SM; Peters-Golden M
    J Pharmacol Exp Ther; 2001 Oct; 299(1):198-203. PubMed ID: 11561080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.
    Pace S; Pergola C; Dehm F; Rossi A; Gerstmeier J; Troisi F; Pein H; Schaible AM; Weinigel C; Rummler S; Northoff H; Laufer S; Maier TJ; Rådmark O; Samuelsson B; Koeberle A; Sautebin L; Werz O
    J Clin Invest; 2017 Aug; 127(8):3167-3176. PubMed ID: 28737505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.